The relaunch that took a challenger brand to No.2 at GPs
Vitaresp FX had been stuck at rank 4 for years while the big names split the market between them. When I took over the brand I rewrote the plan from scratch and relaunched it to 12,000 GPs and 2,000 ENT specialists. A year later it was the second most prescribed brand in its market at GPs, breathing down the leader's neck.
The insight that carried it: patients stopped taking the medicine after 3 days when they needed 4 weeks. So the campaign taught doctors and patients to finish the course. We called it 1-2-3-4, and it ran through everything from Rx pads to the "Goodbye Allergies, Hello Smiles" creative.
- Cut the price and strip size so patients could actually afford the full course. Units grew 60%.
- Moved the field force from print to digital visual aids and saved 30% on print and agency costs.
- Won Emerging Marketer of the Year for this one.
Prescription rank at GPs 2023 to 2025
Rank in prescriptions among GPs in the represented market. Climbed from 4th to 2nd, then held it while the prescriber base grew 80%.













